Adhesions AbdominalPredictionNCT06841146
Prediction of Adhesion by Sliding Sign
A study testing routine cesarean section in people with Adhesions Abdominal, run by Sanliurfa Education and Research Hospital.
Trial summary
Sliding sign will be checked by ultrasonography by transabdominal and transvaginal route before operation of patients that had cesarean section three or more. During cesarean section adhesions will be evaluated and noted. The correlation and predictive values of adhesion and sliding sign will be defined in our study. Read more about this study
- Who is it for?
- Ages 18 to 50 years, women only
- Conditions the study is for
- Adhesions Abdominal
- What is being tested?
- routine cesarean section
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 19 Feb 2025to 31 Mar 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- all three and above number of cesarean section patients
Who cannot join
- -
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Prediction of Adhesion by Sliding Sign in Three or Above Cesarean Section
Sliding sign will be checked by ultrasonography by transabdominal and transvaginal route before operation of patients that had cesarean section three or more. During cesarean section adhesions will be evaluated and noted. The correlation and predictive values of adhesion and sliding sign will be defined in our study.
Read the detailed description
Three or more cesarean section patients will be included in our study. In addition, inflammatory markers in complete blood count as neutrophil, lymphocyte, neutrophil/ lymphocyte ratio, pan immune inflammation value (PIV) will be recorded.
- Conditions
- Adhesions Abdominal
- Being tested
- routine cesarean section
- Keywords
- adhesion, cesarean section, sliding sign
- Medical subject headings
- Tissue Adhesions
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
routine cesarean sectionProcedure or surgery
cesarean section
| Study group | Role | What they receive |
|---|---|---|
| patients that had cesarean section | Active comparator | patients had ultrasonograpy done before cesarean section and sliding sign will be defined,and at cesarean section adhesions will be defined. Receives: Procedure: routine cesarean section |
What is being measured
The primary outcome is the main question the study is designed to answer.
predictive value of sliding sign for adhesions intraabdominally
sensivitivity and specivitivity of sliding sign
Measured: before cesarean section
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Feb 2025
- Study start19 Feb 2025 (estimated)
- Primary completion1 Mar 2025 (estimated)
- Study completion31 Mar 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Adhesions AbdominalStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sanliurfa Education and Research Hospital
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Alev Esercan, Sanliurfa Education and Research Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06841146
- Sponsor's protocol ID
- ŞEAH/CS
- Acronym
- Prediction
- Status last verified
- Feb 2025
- First submitted
- 27 Dec 2024
- Last updated
- 24 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prediction of Adhesion by Sliding Sign in Three or Above Cesarean Section
- ClinicalTrials.gov ID
- NCT06841146
- Acronym / sponsor ID
- Prediction / ŞEAH/CS
- Conditions
- Adhesions Abdominal
- Keywords
- adhesion, cesarean section, sliding sign
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Sanliurfa Education and Research HospitalOther government
- Study start
- 19 Feb 2025 (estimated)
- Primary completion
- 1 Mar 2025 (estimated)
- Study completion
- 31 Mar 2025 (estimated)
- First posted
- 24 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Sliding sign will be checked by ultrasonography by transabdominal and transvaginal route before operation of patients that had cesarean section three or more. During cesarean section adhesions will be evaluated and noted. The correlation and predictive values of adhesion and sliding sign will be defined in our study.
Detailed description
Three or more cesarean section patients will be included in our study. In addition, inflammatory markers in complete blood count as neutrophil, lymphocyte, neutrophil/ lymphocyte ratio, pan immune inflammation value (PIV) will be recorded.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| patients that had cesarean section | Active comparator | Procedure: routine cesarean sectionpatients had ultrasonograpy done before cesarean section and sliding sign will be defined,and at cesarean section adhesions will be defined. |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- all three and above number of cesarean section patients
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| routine cesarean sectioncesarean section | Procedure or surgery | patients that had cesarean section |
Primary outcome
predictive value of sliding sign for adhesions intraabdominally
Time frame: before cesarean section
sensivitivity and specivitivity of sliding sign
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Feb 2025.
- Individual participant dataSharing planned: No
Related trials for Adhesions Abdominal
Enrolling by invitationObservational study
Intestinal Obstruction Surgery. Acute Abdominal Pathology. №9:05/05/2026
Small Bowel Adhesion, Obstruction Bowel
Recruiting
The Effect of Temporary Ovarian Suspension to the Abdominal Wall During Laparoscopic Endometriosis Surgery for Adhesion Prevention -A Comparative and Prospective Study
Endometriosis, Abdominal Adhesions
Not yet recruitingObservational study
Adhesion Prevention in ASBO Surgery Using 4DryField® PH
Adhesive Small Bowel Obstruction, Postoperative Abdominal Adhesions
Active, not recruitingPhase 2
Clinical Study of the Effectiveness, Tolerability and Safety of the Drug "Anti-spike, Gel, 100 g in Bottles in Package No. 1" Produced by the Republican Unitary Enterprise "Unitekhprom BSU", With a Single Intraperitoneal Use After Surgery in Adult Patients With Acute Phlegmonous Appendicitis
Abdominal Adhesions
Active, not recruitingObservational study
Natural Course of Pain Following Surgery Through an Abdominal Incision
Adhesions Abdominal, Adhesions Pelvic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing routine cesarean section in people with Adhesions Abdominal, run by Sanliurfa Education and Research Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 24 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact alev esercan, assoc.prof. (905052634609, alevesercan@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
predictive value of sliding sign for adhesions intraabdominally (time frame: before cesarean section). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2025; AzTrials last refreshed its copy on 6 Nov 2026.